Medtech Innovator

Organization Overview

Medtech Innovator is located in Los Angeles, CA. The organization was established in 2019. According to its NTEE Classification (B90) the organization is classified as: Educational Services, under the broad grouping of Education and related organizations. As of 06/2021, Medtech Innovator employed 15 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Medtech Innovator is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 06/2021, Medtech Innovator generated $4.6m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 48.3% each year . All expenses for the organization totaled $2.4m during the year ending 06/2021. While expenses have increased by 4.2% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Since 2018, Medtech Innovator has awarded 32 individual grants totaling $3,330,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

MEDTECH INNOVATOR ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES.

Describe the Organization's Program Activity:

Part 3 - Line 4a

MEDTECH INNOVATOR ("MTI") ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES. ITS MISSION IS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. WHILE MANY ENTITIES EXIST THAT PROVIDE EARLY-STAGE SUPPORT FOR HEALTH CARE INNOVATION, THESE ORGANIZATIONS COMMONLY ARE REGIONALLY-BASED AND LIMITED BY THE FINANCIAL RESOURCES AND EXPERTISE OF THEIR LOCAL ECOSYSTEMS. AS A RESULT, PROMISING MEDICAL INNOVATIONS RECEIVE EARLY SUPPORT BUT ULTIMATELY FAIL TO REACH PATIENTS. MTI HAS BEEN PURPOSE-BUILT TO IDENTIFY THE MOST VIABLE STARTUPS AND IMMERSE THEM IN THE BEST VIRTUAL MEDTECH ECOSYSTEM IN THE WORLD, NO MATTER WHERE THEY ARE BASED. MTI PROVIDES A RESOURCE-RICH ENVIRONMENT TO ASSIST STARTUPS IN HONING THEIR BUSINESS MODELS, DEVELOPING THEIR VALUE PROPOSITIONS, AND SECURING THEIR NEXT ROUND OF FUNDING, AMONG OTHER CHALLENGES FACED BY COMPANIES ATTEMPTING TO COMMERCIALIZE INNOVATIVE HEALTH TECHNOLOGY FOR THE BENEFIT OF PATIENTS AROUND THE WORLD. IN 2021, MTI LAUNCHED BIOTOOLS INNOVATOR, A NEW INITIATIVE THAT LEVERAGES ITS SUCCESSFUL MODEL TO SUPPORT INNOVATORS IN THE LIFE SCIENCE TOOLS AND DIAGNOSTICS SPACES. 1. MTI UNDERTAKES TWO PRIMARY ACTIVITIES: SECTOR/REGIONAL-BASED COMPETITIONS FOR INNOVATIVE STARTUPS AND A FOUR-MONTH MENTORSHIP-DRIVEN ACCELERATOR FOR THE LEADING APPLICANTS. EACH YEAR, MTI GIVES OUT A COMBINATION OF CASH PRIZES AND IN-KIND AWARDS THROUGH ITS VARIOUS COMPETITIONS, WHICH INCLUDE SEVERAL ROUNDS DURING WHICH THOUSANDS APPLY AND HUNDREDS OF COMPANIES GAIN INCREASING AMOUNTS OF EXPOSURE TO INDUSTRY LEADERS THROUGH ONLINE APPLICATION REVIEWS, IN-PERSON AND VIRTUAL PITCH EVENTS, AND AUDIENCE-DRIVEN, PUBLIC COMPETITIONS IN PARTNERSHIP WITH LEADING INDUSTRY CONFERENCES. AS THE COMPETITION PROGRESSES, COMPANIES ARE ACCEPTED INTO THE ANNUAL COHORT. THESE STARTUPS GAIN CRITICAL INDUSTRY-WIDE VISIBILITY AND ACCESS TO LEADING INVESTORS, MANUFACTURERS, PROVIDERS, AND CUSTOMERS. AMONG MANY BENEFITS, THEY RECEIVE EXCLUSIVE NETWORKING OPPORTUNITIES, INTERACTIVE WORKSHOPS, AND COACHING. THE COMPANIES ALSO HAVE MULTIPLE OCCASIONS TO SHOWCASE THEIR PRODUCTS AND GAIN EXPERIENCE PITCHING TO AUDIENCES OF INDUSTRY STAKEHOLDERS AND DECISION-MAKERS. A SUBSET OF EARLIER-STAGE COMPANIES TAKE PART IN A CUSTOMIZED MENTORSHIP PROGRAM WHERE THEY ARE PAIRED WITH SENIOR LEADERS IN THE MEDICAL TECHNOLOGY (MEDTECH) INDUSTRY. ALL COHORT COMPANIES HAVE THE OPPORTUNITY TO COMPETE FOR CASH PRIZES AND IN-KIND AWARDS, WITH THE LARGEST CASH AWARDS RESERVED FOR THE EARLIER-STAGE COHORT WHERE THESE NON-DILUTIVE FINANCIAL RESOURCES CAN HAVE A SIGNIFICANT IMPACT.2. MTI HAS ATTRACTED TOP TALENT TO OVERSEE THE COMPETITION AND ACCELERATOR PROGRAMS, INCLUDING STAFF MEMBERS WITH ADVANCED DEGREES AND DOCTORATES IN FIELDS OF STUDY RELEVANT TO THE STARTUP COMPANIES THEY ASSIST. MTI STAFFERS HAVE A BROAD KNOWLEDGE AND UNDERSTANDING OF THE MEDICAL TECHNOLOGY AND LIFE SCIENCES INDUSTRIES, INCLUDING THE REGULATORY AND REIMBURSEMENT REQUIREMENTS, THE INVESTMENT ENVIRONMENT, AND THE CLINICAL AND SCIENTIFIC NEEDS FOR RESEARCH AND DEVELOPMENT. MTI ALSO DEVELOPS RELATIONSHIPS WITH HUNDREDS OF INDUSTRY EXECUTIVES, HEALTH CARE PROVIDERS, INVESTORS AND KEY OPINION LEADERS, FOR THE BENEFIT OF COMPANIES PARTICIPATING IN ITS COMPETITION AND ACCELERATOR. MTI BRINGS THESE EXPERTS TOGETHER TO SERVE AS APPLICATION REVIEWERS AND JUDGES AT REGIONAL PITCH EVENTS AND COMPETITIONS, AND THEY OFFER FEEDBACK, GUIDANCE AND MENTORSHIP TO COMPANIES THAT PROGRESS THROUGH THE PROGRAM. THESE EXPERTS VOLUNTEER THEIR TIME TO SUPPORT MTI IN ITS MISSION TO IMPROVE THE LIVES OF PATIENTS.3. THE EVENTS OF THE COMPETITION ARE CONDUCTED THROUGHOUT THE YEAR, WITH APPLICATIONS OPENING IN OCTOBER OF THE PRECEDING YEAR. THE ACCELERATOR PROGRAMS TYPICALLY RUN FROM JUNE THROUGH OCTOBER.4. THE EVENTS OF THE COMPETITION AND ACCELERATOR TAKE PLACE VIRTUALLY AND IN CITIES AROUND THE UNITED STATES, SUCH AS SAN FRANCISCO, LOS ANGELES, SAN DIEGO, RESEARCH TRIANGLE PARK, SEATTLE, CHICAGO, HOUSTON, BOSTON, MINNEAPOLIS, PHILADELPHIA, AND WASHINGTON, D.C., AND IN INTERNATIONAL LOCATIONS SUCH AS IRELAND, ISRAEL, CANADA, JAPAN, AUSTRALIA, CHINA, AND SINGAPORE. THE ACCELERATOR IS A VIRTUAL PROGRAM, LARGELY CONDUCTED VIA WEBINAR AND TELECONFERENCE, IN ADDITION TO MULTI-DAY, IN-PERSON EVENTS HELD AT ITS BEGINNING AND CONCLUSION. ALL OF THE COMPANIES SELECTED FOR MEDTECH INNOVATOR'S ANNUAL COHORT PARTICIPATE IN THE SUMMIT AND FINALS, WHICH BRING TOGETHER SENIOR LEADERSHIP FROM EACH COMPANY ALONG WITH REPRESENTATIVES FROM MEDTECH INNOVATOR'S CORPORATE PARTNERS, REPRESENTATIVES FROM FEDERAL AGENCIES THAT SUPPORT MEDICAL INNOVATION SUCH AS FDA, HHS, DOD, AND NIH, AND KEY STAKEHOLDERS SUCH AS INVESTORS AND HEALTH CARE PROVIDERS.5. MTI SEEKS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF STARTUP COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. THIS WILL BE ACCOMPLISHED BY OFFERING SUBSTANTIVE RESOURCES AND NETWORK CONNECTIONS TO THE STARTUPS LEADING UP TO AND DURING THE ACCELERATOR AS WELL AS PROVIDING DIRECT FUNDING TO SELECT COMPANIES THROUGH AWARDS IN THE COMPETITION. MTI'S ACTIVITIES FURTHER THE PUBLIC GOOD BY UNITING LEADING STAKEHOLDERS IN THE MEDTECH INNOVATION ECOSYSTEM TO SUPPORT AND GUIDE TRANSFORMATIVE EARLY-STAGE COMPANIES THAT ARE STRIVING TO SOLVE UNMET PATIENT NEEDS AND INCREASE EFFICIENCY, QUALITY, EQUITY AND VALUE IN THE HEALTH CARE SYSTEM.6. MTI IS FUNDED BY CORPORATE INDUSTRY DONORS, INCLUDING LEADING MANUFACTURERS, PRIVATE FOUNDATIONS, INVESTORS, SERVICE PROVIDERS, STATE AND FEDERAL TRADE ASSOCIATIONS, AND GRANTS FROM GOVERNMENTAL AGENCIES. MTI HOPES TO INCREASE FINANCIAL SUPPORT FROM GOVERNMENTAL AGENCIES AND PRIVATE FOUNDATIONS THAT SUPPORT HEALTH CARE INNOVATION, AS MTI PROVIDES A UNIQUE FRAMEWORK TO HELP ENSURE THAT IMPORTANT GRANT-SUPPORTED HEALTH CARE TECHNOLOGIES ACTUALLY REACH PATIENTS IN NEED.7. THERE CURRENTLY ARE NO DBAS. MTI'S WEBSITE IS HTTPS://MEDTECHINNOVATOR.ORG.


MEDTECH INNOVATOR ("MTI") ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES. ITS MISSION IS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. WHILE MANY ENTITIES EXIST THAT PROVIDE EARLY-STAGE SUPPORT FOR HEALTH CARE INNOVATION, THESE ORGANIZATIONS COMMONLY ARE REGIONALLY-BASED AND LIMITED BY THE FINANCIAL RESOURCES AND EXPERTISE OF THEIR LOCAL ECOSYSTEMS. AS A RESULT, PROMISING MEDICAL INNOVATIONS RECEIVE EARLY SUPPORT BUT ULTIMATELY FAIL TO REACH PATIENTS. MTI HAS BEEN PURPOSE-BUILT TO IDENTIFY THE MOST VIABLE STARTUPS AND IMMERSE THEM IN THE BEST VIRTUAL MEDTECH ECOSYSTEM IN THE WORLD, NO MATTER WHERE THEY ARE BASED. MTI PROVIDES A RESOURCE-RICH ENVIRONMENT TO ASSIST STARTUPS IN HONING THEIR BUSINESS MODELS, DEVELOPING THEIR VALUE PROPOSITIONS, AND SECURING THEIR NEXT ROUND OF FUNDING, AMONG OTHER CHALLENGES FACED BY COMPANIES ATTEMPTING TO COMMERCIALIZE INNOVATIVE HEALTH TECHNOLOGY FOR THE BENEFIT OF PATIENTS AROUND THE WORLD. IN 2021, MTI LAUNCHED BIOTOOLS INNOVATOR, A NEW INITIATIVE THAT LEVERAGES ITS SUCCESSFUL MODEL TO SUPPORT INNOVATORS IN THE LIFE SCIENCE TOOLS AND DIAGNOSTICS SPACES. 1. MTI UNDERTAKES TWO PRIMARY ACTIVITIES: SECTOR/REGIONAL-BASED COMPETITIONS FOR INNOVATIVE STARTUPS AND A FOUR-MONTH MENTORSHIP-DRIVEN ACCELERATOR FOR THE LEADING APPLICANTS. EACH YEAR, MTI GIVES OUT A COMBINATION OF CASH PRIZES AND IN-KIND AWARDS THROUGH ITS VARIOUS COMPETITIONS, WHICH INCLUDE SEVERAL ROUNDS DURING WHICH THOUSANDS APPLY AND HUNDREDS OF COMPANIES GAIN INCREASING AMOUNTS OF EXPOSURE TO INDUSTRY LEADERS THROUGH ONLINE APPLICATION REVIEWS, IN-PERSON AND VIRTUAL PITCH EVENTS, AND AUDIENCE-DRIVEN, PUBLIC COMPETITIONS IN PARTNERSHIP WITH LEADING INDUSTRY CONFERENCES. AS THE COMPETITION PROGRESSES, COMPANIES ARE ACCEPTED INTO THE ANNUAL COHORT. THESE STARTUPS GAIN CRITICAL INDUSTRY-WIDE VISIBILITY AND ACCESS TO LEADING INVESTORS, MANUFACTURERS, PROVIDERS, AND CUSTOMERS. AMONG MANY BENEFITS, THEY RECEIVE EXCLUSIVE NETWORKING OPPORTUNITIES, INTERACTIVE WORKSHOPS, AND COACHING. THE COMPANIES ALSO HAVE MULTIPLE OCCASIONS TO SHOWCASE THEIR PRODUCTS AND GAIN EXPERIENCE PITCHING TO AUDIENCES OF INDUSTRY STAKEHOLDERS AND DECISION-MAKERS. A SUBSET OF EARLIER-STAGE COMPANIES TAKE PART IN A CUSTOMIZED MENTORSHIP PROGRAM WHERE THEY ARE PAIRED WITH SENIOR LEADERS IN THE MEDICAL TECHNOLOGY (MEDTECH) INDUSTRY. ALL COHORT COMPANIES HAVE THE OPPORTUNITY TO COMPETE FOR CASH PRIZES AND IN-KIND AWARDS, WITH THE LARGEST CASH AWARDS RESERVED FOR THE EARLIER-STAGE COHORT WHERE THESE NON-DILUTIVE FINANCIAL RESOURCES CAN HAVE A SIGNIFICANT IMPACT.2. MTI HAS ATTRACTED TOP TALENT TO OVERSEE THE COMPETITION AND ACCELERATOR PROGRAMS, INCLUDING STAFF MEMBERS WITH ADVANCED DEGREES AND DOCTORATES IN FIELDS OF STUDY RELEVANT TO THE STARTUP COMPANIES THEY ASSIST. MTI STAFFERS HAVE A BROAD KNOWLEDGE AND UNDERSTANDING OF THE MEDICAL TECHNOLOGY AND LIFE SCIENCES INDUSTRIES, INCLUDING THE REGULATORY AND REIMBURSEMENT REQUIREMENTS, THE INVESTMENT ENVIRONMENT, AND THE CLINICAL AND SCIENTIFIC NEEDS FOR RESEARCH AND DEVELOPMENT. MTI ALSO DEVELOPS RELATIONSHIPS WITH HUNDREDS OF INDUSTRY EXECUTIVES, HEALTH CARE PROVIDERS, INVESTORS AND KEY OPINION LEADERS, FOR THE BENEFIT OF COMPANIES PARTICIPATING IN ITS COMPETITION AND ACCELERATOR. MTI BRINGS THESE EXPERTS TOGETHER TO SERVE AS APPLICATION REVIEWERS AND JUDGES AT REGIONAL PITCH EVENTS AND COMPETITIONS, AND THEY OFFER FEEDBACK, GUIDANCE AND MENTORSHIP TO COMPANIES THAT PROGRESS THROUGH THE PROGRAM. THESE EXPERTS VOLUNTEER THEIR TIME TO SUPPORT MTI IN ITS MISSION TO IMPROVE THE LIVES OF PATIENTS.3. THE EVENTS OF THE COMPETITION ARE CONDUCTED THROUGHOUT THE YEAR, WITH APPLICATIONS OPENING IN OCTOBER OF THE PRECEDING YEAR. THE ACCELERATOR PROGRAMS TYPICALLY RUN FROM JUNE THROUGH OCTOBER.4. THE EVENTS OF THE COMPETITION AND ACCELERATOR TAKE PLACE VIRTUALLY AND IN CITIES AROUND THE UNITED STATES, SUCH AS SAN FRANCISCO, LOS ANGELES, SAN DIEGO, RESEARCH TRIANGLE PARK, SEATTLE, CHICAGO, HOUSTON, BOSTON, MINNEAPOLIS, PHILADELPHIA, AND WASHINGTON, D.C., AND IN INTERNATIONAL LOCATIONS SUCH AS IRELAND, ISRAEL, CANADA, JAPAN, AUSTRALIA, CHINA, AND SINGAPORE. THE ACCELERATOR IS A VIRTUAL PROGRAM, LARGELY CONDUCTED VIA WEBINAR AND TELECONFERENCE, IN ADDITION TO MULTI-DAY, IN-PERSON EVENTS HELD AT ITS BEGINNING AND CONCLUSION. ALL OF THE COMPANIES SELECTED FOR MEDTECH INNOVATOR'S ANNUAL COHORT PARTICIPATE IN THE SUMMIT AND FINALS, WHICH BRING TOGETHER SENIOR LEADERSHIP FROM EACH COMPANY ALONG WITH REPRESENTATIVES FROM MEDTECH INNOVATOR'S CORPORATE PARTNERS, REPRESENTATIVES FROM FEDERAL AGENCIES THAT SUPPORT MEDICAL INNOVATION SUCH AS FDA, HHS, DOD, AND NIH, AND KEY STAKEHOLDERS SUCH AS INVESTORS AND HEALTH CARE PROVIDERS.5. MTI SEEKS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF STARTUP COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. THIS WILL BE ACCOMPLISHED BY OFFERING SUBSTANTIVE RESOURCES AND NETWORK CONNECTIONS TO THE STARTUPS LEADING UP TO AND DURING THE ACCELERATOR AS WELL AS PROVIDING DIRECT FUNDING TO SELECT COMPANIES THROUGH AWARDS IN THE COMPETITION. MTI'S ACTIVITIES FURTHER THE PUBLIC GOOD BY UNITING LEADING STAKEHOLDERS IN THE MEDTECH INNOVATION ECOSYSTEM TO SUPPORT AND GUIDE TRANSFORMATIVE EARLY-STAGE COMPANIES THAT ARE STRIVING TO SOLVE UNMET PATIENT NEEDS AND INCREASE EFFICIENCY, QUALITY, EQUITY AND VALUE IN THE HEALTH CARE SYSTEM.6. MTI IS FUNDED BY CORPORATE INDUSTRY DONORS, INCLUDING LEADING MANUFACTURERS, PRIVATE FOUNDATIONS, INVESTORS, SERVICE PROVIDERS, STATE AND FEDERAL TRADE ASSOCIATIONS, AND GRANTS FROM GOVERNMENTAL AGENCIES. MTI HOPES TO INCREASE FINANCIAL SUPPORT FROM GOVERNMENTAL AGENCIES AND PRIVATE FOUNDATIONS THAT SUPPORT HEALTH CARE INNOVATION, AS MTI PROVIDES A UNIQUE FRAMEWORK TO HELP ENSURE THAT IMPORTANT GRANT-SUPPORTED HEALTH CARE TECHNOLOGIES ACTUALLY REACH PATIENTS IN NEED.7. THERE CURRENTLY ARE NO DBAS. MTI'S WEBSITE IS HTTPS://MEDTECHINNOVATOR.ORG.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Paul Grand
CEO & President
$564,210
Kathryn Zavala
COO
$192,500
Brian Benson
Vp, Strategic Alliances
$138,500
Christopher Martin
Director
$0
Scott Whitaker
Director
$0

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $220,800
All other contributions, gifts, grants, and similar amounts not included above$4,361,314
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$4,582,114
Total Program Service Revenue$0
Investment income $1,089
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $4,583,203

Grants Awarded

Over the last fiscal year, Medtech Innovator has awarded $850,000 in support to 8 organizations.

Grant RecipientAmount

RHAEOS

PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION

$350,000

RHAEOS

PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION

$350,000

LIEF THERAPEUTICS

PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION

$35,000

LIEF THERAPEUTICS

PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION

$35,000

PROJECT MORAY INC

PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION

$25,000

PROJECT MORAY INC

PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION

$25,000
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 4 grants that Medtech Innovator has recieved totaling $6,000,000.

Awarding OrganizationAmount
Frederick Gardner Cottrell Foundation

Tucson, AZ

PURPOSE: CHARITABLE ENTITY SUPPORT

$2,600,000
Frederick Gardner Cottrell Foundation

Tucson, AZ

PURPOSE: CHARITABLE ENTITY SUPPORT

$2,600,000
Frederick Gardner Cottrell Foundation

Tucson, AZ

PURPOSE: CHARITABLE ENTITY SUPPORT

$400,000
Frederick Gardner Cottrell Foundation

Tucson, AZ

PURPOSE: CHARITABLE ENTITY SUPPORT

$400,000
View Grant Recipient Profile

Peer Organizations

Create an account to unlock the data you need.

or